Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances Smith

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Nursing Times|September 13, 2002
Setting standards for clinical care in ScotlandFrances Smith
American Journal of Clinical Dermatology|April 12, 2003
The molecular genetics of keratin disordersFrances Smith
Therapeutics and Clinical Risk Management|January 9, 2010
In-hospital resuscitation: opioids and other factors influencing survivalKaramarie Fecho, Freeman Jackson, Frances Smith, et al.
Archives of Women'S Mental Health|March 3, 2012
Outcomes from implementing systematic antepartum depression screening in obstetricsPaul Rowan, Anthony Greisinger, Brenda Brehm, et al.
Frontiers in Immunology|July 14, 2022
Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus ErythematosusJessica M Jones, Frances Smith, Emily Littlejohn, et al.
Dermatologic Therapy|August 1, 2019
Pachyonychia congenita responding favorably to a combination of surgical and medical therapiesManju Daroach, Sunil Dogra, Rajsmita Bhattacharjee, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatinJee Eun Lee, Rolf van Heeswijk, Katia Alves, et al.
Journal of Clinical Pharmacology|November 1, 2011
The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevirVarun Garg, Rolf van Heeswijk, Yijun Yang, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2012
Effect of telaprevir on the pharmacokinetics of buprenorphine in volunteers on stable buprenorphine/naloxone maintenance therapyXia Luo, Jose Trevejo, Rolf P G van Heeswijk, et al.
Perspectives of the ASHA Special Interest Groups|June 25, 2026
Asynchronous Telehealth for Dysphagia Management: Evidence, Possibilities, and Practical ExamplesCagla Kantarcigil, Rebecca Frances Smith, Bonnie Martin-Harris, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Nursing Times|September 13, 2002
Setting standards for clinical care in ScotlandFrances Smith
American Journal of Clinical Dermatology|April 12, 2003
The molecular genetics of keratin disordersFrances Smith
Therapeutics and Clinical Risk Management|January 9, 2010
In-hospital resuscitation: opioids and other factors influencing survivalKaramarie Fecho, Freeman Jackson, Frances Smith, et al.
Archives of Women'S Mental Health|March 3, 2012
Outcomes from implementing systematic antepartum depression screening in obstetricsPaul Rowan, Anthony Greisinger, Brenda Brehm, et al.
Frontiers in Immunology|July 14, 2022
Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus ErythematosusJessica M Jones, Frances Smith, Emily Littlejohn, et al.
Dermatologic Therapy|August 1, 2019
Pachyonychia congenita responding favorably to a combination of surgical and medical therapiesManju Daroach, Sunil Dogra, Rajsmita Bhattacharjee, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatinJee Eun Lee, Rolf van Heeswijk, Katia Alves, et al.
Journal of Clinical Pharmacology|November 1, 2011
The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevirVarun Garg, Rolf van Heeswijk, Yijun Yang, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2012
Effect of telaprevir on the pharmacokinetics of buprenorphine in volunteers on stable buprenorphine/naloxone maintenance therapyXia Luo, Jose Trevejo, Rolf P G van Heeswijk, et al.
Perspectives of the ASHA Special Interest Groups|June 25, 2026
Asynchronous Telehealth for Dysphagia Management: Evidence, Possibilities, and Practical ExamplesCagla Kantarcigil, Rebecca Frances Smith, Bonnie Martin-Harris, et al.
Pageof 4